Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzydamine Hydrochloride Spray for Post-operative Sore Throat
NCT06676748Phase 1Recruiting
- Sponsor
- KK Women's and Children's Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of benzydamine in postoperative sore throat (POST) (2 arms), sponsored by KK Women's and Children's Hospital. Primary endpoint: Incidence of Postoperative Sore Throat at 4 hours. Started Aug 2025; status: recruiting.
02
Drugs
benzydamine
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT06676748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06676748.